GlassScriptPhysician profile
Joseph D Mills
NPI 1396027207
$8,795.78
in general payments reported to CMS, 2019-2025
33 companies · $793 in 2025
The $793 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $315 · 2021: $470 · 2022: $2,871 · 2023: $2,148 · 2024: $2,026 · 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,517 · Travel and Lodging: $1,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,516.91 |
| Travel and Lodging | $1,449.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,868.30 | 2020-2025 | |
| Thd America, INC. | $1,177.27 | 2021-2025 | |
| Prodigy Surgical Distribution, INC. | $1,053.31 | 2023 | |
| Stryker Corporation | $503.93 | 2022 | |
| Ethicon US, LLC | $465.99 | 2020-2024 | Echelon Circular, Ethicon, Echelon Flex |
| Integra Lifesciences Corporation | $393.09 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Pentax of America, INC. | $368.96 | 2021-2023 | Inspira |
| Fujifilm Healthcare Americas Corporation | $355.43 | 2023-2024 | Fujifilm |
| Axonics, INC. | $288.33 | 2020-2024 | Axonics |
| Medtronic, INC. | $271.78 | 2022-2024 | Progrip, Sonicision, Eea |
| Coloplast Corp | $255.80 | 2023-2025 | Sensura Mio |
| Abbvie INC. | $220.96 | 2023-2025 | |
| Exact Sciences Corporation | $216.96 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Kerecis Limited | $192.29 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Tela Bio, INC. | $151.46 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $147.06 | 2022 | |
| Kci USA, INC. | $141.36 | 2022-2023 | Activ.A.C., V.A.C. Dermatac |
| Sanara Medtech INC. | $104.89 | 2024 | Celleraterx |
| Erbe USA INC | $90.00 | 2024 | Vio3 |
| Medical Device Business Services, INC. | $89.01 | 2019 | |
| Cook Medical LLC | $84.59 | 2019 | |
| Conmed Corporation | $50.21 | 2025 | Airseal |
| Phathom Pharmaceuticals, INC. | $49.08 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $39.86 | 2022-2024 | Entyvio |
| Braintree Laboratories, INC. | $36.43 | 2020-2021 | |
| Hollister Incorporated | $30.03 | 2022 | |
| Procept Biorobotics Corporation | $29.44 | 2024 | Aquabeam System |
| Solventum Corporation | $27.97 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Regeneron Healthcare Solutions, INC. | $25.06 | 2024 | Dupixent |
| Janssen Biotech, INC. | $19.17 | 2023 | Stelara |
| Arthrex, INC. | $18.00 | 2023 | |
| Ferring Pharmaceuticals INC. | $17.07 | 2023 | Rebyota |
| Innovation Technologies INC | $12.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.